|
(b)(4).A manufacturing record evaluation was performed for the finished device lot number qkmplq, and no non-conformances related to the reported complaint condition were identified.(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested and the following was obtained: was there any patient consequences? no consequences to the patient.How the procedure was completed? a new suture was opened to complete the procedure.Was the broken piece removed from the patients body? the broken piece was located and removed from the patient.Device status- sample of broken needle not available if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Date sent to the fda: 05/20/2021.Additional information: d9, h6.Additional h6 component code: g07002 ¿ conforming device additional h-3 summary: visual inspection and functional test evaluation were conducted on the returned device.Visual analysis of the returned sample determined that eleven samples of product code 752 were received for evaluation.Visual inspection of eleven unopened samples and no defects were found on the packages.The samples were opened, and the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along of the strand and no defects or damaged were observed.A functional test was performed using an instron and the pull force were above the minimum requirements.The event described could not be confirmed as the device performed without any defect noted and the complaint sample was not received for evaluation.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Date sent to the fda: 05/20/2021 this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|